These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 9481038)

  • 21. 3-Coumaranone derivatives as inhibitors of monoamine oxidase.
    Van Dyk AS; Petzer JP; Petzer A; Legoabe LJ
    Drug Des Devel Ther; 2015; 9():5479-89. PubMed ID: 26491258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of monoamine oxidase by phthalide analogues.
    Strydom B; Bergh JJ; Petzer JP
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1269-73. PubMed ID: 23374869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer's disease.
    Patil PO; Bari SB; Firke SD; Deshmukh PK; Donda ST; Patil DA
    Bioorg Med Chem; 2013 May; 21(9):2434-50. PubMed ID: 23517722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benzyloxynitrostyrene analogues - A novel class of selective and highly potent inhibitors of monoamine oxidase B.
    Van der Walt MM; Terre'Blanche G; Petzer JP; Petzer A
    Eur J Med Chem; 2017 Jan; 125():1193-1199. PubMed ID: 27855360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New pyrrole inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.
    La Regina G; Silvestri R; Artico M; Lavecchia A; Novellino E; Befani O; Turini P; Agostinelli E
    J Med Chem; 2007 Mar; 50(5):922-31. PubMed ID: 17256833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2-Azolylchromone Derivatives as Potent and Selective Inhibitors of Monoamine Oxidases A and B.
    Takao K; Saito T; Chikuda D; Sugita Y
    Chem Pharm Bull (Tokyo); 2016; 64(10):1499-1504. PubMed ID: 27725503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Benzopyrone Biochanin-A as a reversible, competitive, and selective monoamine oxidase B inhibitor.
    Zarmouh NO; Eyunni SK; Soliman KF
    BMC Complement Altern Med; 2017 Jan; 17(1):34. PubMed ID: 28069007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-function relationships of mitochondrial monoamine oxidase A and B: chimaeric enzymes and site-directed mutagenesis studies.
    Cesura AM; Gottowik J; Lang G; Malherbe P; Da Prada M
    J Neural Transm Suppl; 1998; 52():189-200. PubMed ID: 9564619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel polyamine analogues: from substrates towards potential inhibitors of monoamine oxidases.
    Bonaiuto E; Milelli A; Cozza G; Tumiatti V; Marchetti C; Agostinelli E; Fimognari C; Hrelia P; Minarini A; Di Paolo ML
    Eur J Med Chem; 2013; 70():88-101. PubMed ID: 24140951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of selective inhibitors for computer modeling of the monoamine oxidase active site].
    Veselovskiĭ AV; Ivanov AS; Medvedev AE
    Vopr Med Khim; 1997; 43(6):527-36. PubMed ID: 9503570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling.
    Gallardo-Godoy A; Fierro A; McLean TH; Castillo M; Cassels BK; Reyes-Parada M; Nichols DE
    J Med Chem; 2005 Apr; 48(7):2407-19. PubMed ID: 15801832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives.
    Chimenti F; Fioravanti R; Bolasco A; Manna F; Chimenti P; Secci D; Rossi F; Turini P; Ortuso F; Alcaro S; Cardia MC
    Eur J Med Chem; 2008 Oct; 43(10):2262-7. PubMed ID: 18281126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Focusing on new monoamine oxidase inhibitors: differently substituted coumarins as an interesting scaffold.
    Matos MJ; Viña D; Vazquez-Rodriguez S; Uriarte E; Santana L
    Curr Top Med Chem; 2012; 12(20):2210-39. PubMed ID: 23231397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, Biological Evaluation, and Molecular Simulation of Chalcones and Aurones as Selective MAO-B Inhibitors.
    Morales-Camilo N; Salas CO; Sanhueza C; Espinosa-Bustos C; Sepúlveda-Boza S; Reyes-Parada M; Gonzalez-Nilo F; Caroli-Rezende M; Fierro A
    Chem Biol Drug Des; 2015 Jun; 85(6):685-95. PubMed ID: 25346162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and molecular modelling of novel substituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase-A inhibitors.
    Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F
    Chem Biol Drug Des; 2006 Mar; 67(3):206-14. PubMed ID: 16611214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2-Heteroarylidene-1-indanone derivatives as inhibitors of monoamine oxidase.
    Nel MS; Petzer A; Petzer JP; Legoabe LJ
    Bioorg Chem; 2016 Dec; 69():20-28. PubMed ID: 27662218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoamine oxidases: the biochemistry of the proteins as targets in medicinal chemistry and drug discovery.
    Ramsay RR
    Curr Top Med Chem; 2012; 12(20):2189-209. PubMed ID: 23231396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selected C7-substituted chromone derivatives as monoamine oxidase inhibitors.
    Legoabe LJ; Petzer A; Petzer JP
    Bioorg Chem; 2012 Dec; 45():1-11. PubMed ID: 23064123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and evaluation of biaryl derivatives for structural characterization of selective monoamine oxidase B inhibitors toward Parkinson's disease therapy.
    Yeon SK; Choi JW; Park JH; Lee YR; Kim HJ; Shin SJ; Jang BK; Kim S; Bahn YS; Han G; Lee YS; Pae AN; Park KD
    Bioorg Med Chem; 2018 Jan; 26(1):232-244. PubMed ID: 29198609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and biochemical evaluation of novel multi-target inhibitors as potential anti-Parkinson agents.
    Carradori S; Ortuso F; Petzer A; Bagetta D; De Monte C; Secci D; De Vita D; Guglielmi P; Zengin G; Aktumsek A; Alcaro S; Petzer JP
    Eur J Med Chem; 2018 Jan; 143():1543-1552. PubMed ID: 29126727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.